Literature DB >> 10843388

Rac2 stimulates Akt activation affecting BAD/Bcl-XL expression while mediating survival and actin function in primary mast cells.

F C Yang1, R Kapur, A J King, W Tao, C Kim, J Borneo, R Breese, M Marshall, M C Dinauer, D A Williams.   

Abstract

Mast cells generated from Rac2-deficient (-/-) mice demonstrated defective actin-based functions, including adhesion, migration, and degranulation. Rac2(-/-) mast cells generated lower numbers and less mast cell colonies in response to growth factors and were deficient in vivo. Rac2(-/-) mast cells demonstrated a significant reduction in growth factor-induced survival, which correlated with the lack of activation of Akt and significant changes in the expression of the Bcl-2 family members BAD and Bcl-XL, in spite of a 3-fold induction of Rac1 protein. These results suggest that Rac2 plays a unique role in multiple cellular functions and describe an essential role for Rac2 in growth factor-dependent survival and expression of BAD/Bcl-XL.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843388     DOI: 10.1016/s1074-7613(00)80207-1

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  57 in total

1.  Rac and Cdc42 GTPases control hematopoietic stem cell shape, adhesion, migration, and mobilization.

Authors:  F C Yang; S J Atkinson; Y Gu; J B Borneo; A W Roberts; Y Zheng; J Pennington; D A Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

Review 2.  Regulation of cell polarity during eukaryotic chemotaxis: the chemotactic compass.

Authors:  Orion D Weiner
Journal:  Curr Opin Cell Biol       Date:  2002-04       Impact factor: 8.382

3.  On how Rac controls hematopoietic stem cell activity.

Authors:  J A Cancelas
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

4.  SWAP-70 regulates c-kit-induced mast cell activation, cell-cell adhesion, and migration.

Authors:  Raja Rajeswari Sivalenka; Rolf Jessberger
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

Review 5.  Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.

Authors:  Karl Staser; Feng-Chun Yang; D Wade Clapp
Journal:  Annu Rev Pathol       Date:  2011-11-07       Impact factor: 23.472

6.  Nf1-/- Schwann cell-conditioned medium modulates mast cell degranulation by c-Kit-mediated hyperactivation of phosphatidylinositol 3-kinase.

Authors:  Shi Chen; Sarah Burgin; Andrew McDaniel; Xiaohong Li; Jin Yuan; Mia Chen; Waleed Khalaf; D Wade Clapp; Feng-Chun Yang
Journal:  Am J Pathol       Date:  2010-10-29       Impact factor: 4.307

7.  p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics.

Authors:  Jayme D Allen; Zahara M Jaffer; Su-Jung Park; Sarah Burgin; Clemens Hofmann; Mary Ann Sells; Shi Chen; Ethel Derr-Yellin; Elizabeth G Michels; Andrew McDaniel; Waylan K Bessler; David A Ingram; Simon J Atkinson; Jeffrey B Travers; Jonathan Chernoff; D Wade Clapp
Journal:  Blood       Date:  2009-01-05       Impact factor: 22.113

8.  The p85alpha subunit of class IA phosphatidylinositol 3-kinase regulates the expression of multiple genes involved in osteoclast maturation and migration.

Authors:  Veerendra Munugalavadla; Sasidhar Vemula; Emily Catherine Sims; Subha Krishnan; Shi Chen; Jincheng Yan; Huijie Li; Paul J Niziolek; Clifford Takemoto; Alexander G Robling; Feng-Chun Yang; Reuben Kapur
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

9.  RASAL3 preferentially stimulates GTP hydrolysis of the Rho family small GTPase Rac2.

Authors:  Yoonjae Shin; Yong Woo Kim; Hyemin Kim; Nakyoung Shin; Tae Sung Kim; Taeg Kyu Kwon; Jang Hyun Choi; Jong-Soo Chang
Journal:  Biomed Rep       Date:  2018-07-02

Review 10.  Rho GTPases in hematopoiesis and hemopathies.

Authors:  James C Mulloy; Jose A Cancelas; Marie-Dominique Filippi; Theodosia A Kalfa; Fukun Guo; Yi Zheng
Journal:  Blood       Date:  2009-11-24       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.